Tube thoracostomy is one of the most frequently performed procedures in trauma, and one of the most stubbornly traditional. With an estimated 300,000 traumatic haemothoraces occurring in the United States each year, the chest drain is a daily intervention in trauma bays worldwide. Yet much of what is taught about it - the calibre of tube, where to put a needle, when a small pneumothorax can simply be watched - rests on convention as much as on trial data. That gap matters, because in November 2025 the World Journal of Emergency Surgery published a meta-analysis of randomised trials, complete with trial sequential analysis, asking a question the Advanced Trauma Life Support (ATLS) course has long answered by reflex: does the size of the tube actually change outcomes? The honest answer is increasingly “probably not.”
For candidates sitting ATLS examinations, this creates a familiar tension. The course teaches a defensible, standardised approach designed to keep patients alive in the first ten minutes. The literature, meanwhile, is moving - sometimes faster than the curriculum. Understanding both, and knowing where they diverge, is exactly the sort of nuance that separates a competent candidate from an excellent one.
The size question: does a 14-French drain really work?
Classical teaching, reflected in successive editions of ATLS, has favoured large-bore tubes - typically 28 to 32 French, historically up to 40 French - for traumatic haemothorax, on the intuitive grounds that blood is viscous and a wider tube drains it faster and resists clotting. The intuition is reasonable. The evidence has not cooperated.
The pivotal work came from the Arizona group. In their 2014 British Journal of Surgery randomised trial, Kulvatunyou and colleagues showed that 14-French pigtail catheters managed uncomplicated traumatic pneumothorax as effectively as 28-French tubes, with markedly lower tube-site pain. Their 2021 multicentre P-CAT trial in the Journal of Trauma and Acute Care Surgery extended the comparison to haemothorax: 14-French percutaneous catheters and 28- to 32-French chest tubes produced comparable failure rates and drainage, while patients found the smaller catheter considerably more tolerable to insert. A parallel randomised trial led by Bauman, published in World Journal of Surgery the same year, reached the same conclusion - that, for drainage of blood, calibre did not determine success.
The pattern has held in newer data. A 2025 non-inferiority randomised trial in The American Surgeon by McCartt and colleagues compared a 14-French Thal tube against a 28-French tube for traumatic haemothorax and again found no clinically meaningful disadvantage to going small. Pulling the strands together, the 2025 World Journal of Emergency Surgery meta-analysis by Granieri and colleagues synthesised the randomised evidence for small-calibre (≤14 French) versus large-bore (≥28 French) tubes across haemothorax, haemopneumothorax and pneumothorax. Small tubes delivered similar treatment-failure rates with fewer insertion-related complications, and the authors used trial sequential analysis specifically to test whether the cumulative sample is yet large enough to be conclusive - a more honest treatment of uncertainty than most narrative reviews offer.
This is not a settled debate, and it would be a mistake to present it as one. The total randomised population remains modest, most trials deliberately excluded the haemodynamically unstable patient who needs an emergency tube, and a 14-French catheter blocked by clot in a brisk bleed is a real and dangerous failure mode. The Annals of Emergency Medicine “Clinical Controversies” feature in January 2025 laid out precisely these diverging views, noting how little high-quality evidence underpins a choice made thousands of times a day. The reasonable reading is not “small tubes win” but rather that, in the selected, stable patient, the reflex reach for the largest tube on the trolley is no longer evidence-based.
Decompressing tension: needle, knife, or finger?
If the size debate is quietly evolving, the decompression debate is openly contested. Tension pneumothorax is a clinical diagnosis demanding immediate action, and for decades that action was needle decompression in the second intercostal space at the mid-clavicular line. The problem is that it frequently fails to reach the pleura at all.
A 2024 systematic review and meta-analysis pooling radiological data from more than 8,000 patients estimated that a standard needle fails to penetrate the pleural cavity in roughly one in three attempts at conventional sites. The same analysis quantified a relationship clinicians can act on: each additional centimetre of needle length cut the failure rate by around eight per cent, and chest-wall thickness was consistently lower at the fifth intercostal space than at the second. Individual cohorts have reported even starker contrasts, with second-space failure rates above 40 per cent against roughly 17 per cent at the fifth-space mid-axillary position. It is this body of evidence that prompted the shift, reflected in the tenth edition of ATLS, towards the fifth intercostal space anterior to the mid-axillary line and a longer catheter for adults.
Longer needles and better landmarks address the depth problem but not the reliability problem, which is why many trauma services - particularly in the pre-hospital and resuscitation setting - have moved towards finger thoracostomy: a deliberate incision and blunt dissection into the pleural space, giving tactile confirmation that the cavity has been entered. Matched-cohort data published in 2024 found higher rates of successful intrathoracic decompression with finger thoracostomy than with the needle. The evidence is not one-directional, however. A systematic review of pre-hospital decompression concluded that the superiority of either technique remains genuinely unproven, and at least one analysis associated finger thoracostomy with higher mortality - almost certainly a marker of sicker patients selected for the more invasive procedure rather than harm from the technique itself. Finger thoracostomy also carries its own burdens: infection risk, the need for adequate training, and the reality that an open thoracostomy left without a tube can re-accumulate.
For the examination candidate the safest synthesis is this: needle decompression is fast and familiar but unreliable, and where it is used the needle must be long enough and placed low enough; finger thoracostomy is more dependable in trained hands; and the definitive answer in every case remains a chest drain.
The occult pneumothorax dilemma
Whole-body computed tomography has created a problem the chest radiograph never posed: the occult pneumothorax, invisible on plain film but obvious on CT. Once you can see it, the instinct is to treat it. The evidence suggests restraint is often safer than a drain.
The Eastern Association for the Surgery of Trauma practice management guideline on haemothorax and occult pneumothorax concluded that a stable patient with an occult pneumothorax may be observed - even when receiving positive-pressure ventilation, the very scenario clinicians most fear will precipitate tension. That position rests substantially on a prospective American Association for the Surgery of Trauma multicentre study by Moore and colleagues, in which only around six per cent of observed patients ultimately required a tube, and failures were predicted by radiographic progression and symptoms rather than by ventilation alone. The same guideline reminds clinicians that a chest tube is not a benign object: insertion complication rates in the literature run from roughly nine to twenty-five per cent, and post-traumatic empyema is a recognised consequence.
The corollary matters too. Where drainage is undertaken and a problem persists - a retained haemothorax or an air leak still present on the third post-injury day - the guidelines favour early video-assisted thoracoscopic surgery rather than repeated blind tube insertion. The clinical art lies in identifying which occult pneumothorax can be watched and which is quietly enlarging; scoring systems have repeatedly proved poor at this, leaving serial imaging and clinical vigilance as the mainstay.
Antibiotics: prophylaxis, presumptive, or pointless?
Few chest-drain questions have generated more contradictory guidance than antibiotics. Because the pleural cavity is already breached by the time a trauma patient reaches care, drugs given afterwards are arguably “presumptive” rather than truly prophylactic, and for years the teaching held that they reduced pneumonia but not empyema, recommending at most a 24-hour course of a first-generation cephalosporin.
The 2022 Eastern Association for the Surgery of Trauma guideline, published in Trauma Surgery & Acute Care Open, reframes that conclusion. Pooling fourteen studies, the working group found that antibiotic prophylaxis at the time of tube insertion was associated with a significant reduction in empyema - an odds ratio of around 0.47 - with the benefit concentrated in penetrating injury, where the odds of empyema fell by roughly three-quarters. Notably, and contrary to the older teaching, the analysis found no significant effect on pneumonia or on mortality. The recommendation is therefore conditional: give antibiotics at insertion to reduce empyema, while acknowledging that the evidence is of limited certainty and that antimicrobial stewardship pulls in the opposite direction. It is a textbook example of guidelines updating against the grain of what many clinicians were originally taught.
What this means for the ATLS candidate
ATLS exists to standardise the first, life-saving phase of trauma care, and its core teaching on the chest remains sound: tension pneumothorax is a clinical diagnosis treated by immediate decompression; open pneumothorax needs a vented dressing; massive haemothorax - conventionally an initial drainage of more than 1,500 mL or ongoing losses of around 200 mL per hour - mandates operative consultation; and the definitive management of air or blood in the pleural space is a correctly sited chest drain in the fifth intercostal space, anterior to the mid-axillary line, within the “safe triangle.” Candidates should be able to reproduce this without hesitation.
Where examinations increasingly probe is the boundary between the protocol and the evidence. Strong candidates should be able to explain that ATLS has already moved the recommended needle-decompression site and lengthened the catheter in response to failure-rate data; that small-bore catheters are a legitimate, evidence-supported option for the stable patient even though large-bore tubes remain the taught default; that an occult pneumothorax on CT does not automatically require a drain; and that current guidance supports antibiotic prophylaxis at insertion chiefly to prevent empyema. Equally, the disciplined candidate knows the limits of these arguments - the exclusion of unstable patients from the tube-size trials, the clot-blockage risk of a narrow catheter, and the unresolved needle-versus-finger question - and does not mistake an emerging signal for established doctrine.
Thoracic trauma is heavily represented in ATLS assessment because it kills quickly and is so often correctable with a simple procedure. The chest drain sits at the centre of that story. Knowing not only how to insert one, but when a smaller tube will do, when no tube is needed at all, and what the evidence does and does not yet support, is precisely the kind of layered understanding that high-quality questions are designed to reward.
References
1. Granieri S, Cioffi SPB, Asaro A, et al. Small versus large bore chest tube in traumatic hemothorax, hemopneumothorax, and pneumothorax: a meta-analysis of randomized controlled trials with trial sequential analysis. World J Emerg Surg. 2025;20:87. doi:10.1186/s13017-025-00655-x. https://doi.org/10.1186/s13017-025-00655-x
2. Kulvatunyou N, Bauman ZM, Zein Edine SB, et al. The small (14 Fr) percutaneous catheter (P-CAT) versus large (28-32 Fr) open chest tube for traumatic hemothorax: a multicenter randomized clinical trial. J Trauma Acute Care Surg. 2021;91(5):809-813. doi:10.1097/TA.0000000000003180. https://pubmed.ncbi.nlm.nih.gov/33843831/
3. Bauman ZM, Kulvatunyou N, Joseph B, et al. Randomized clinical trial of 14-French (14F) pigtail catheters versus 28-32F chest tubes in the management of patients with traumatic hemothorax and hemopneumothorax. World J Surg. 2021;45(3):880-886. doi:10.1007/s00268-020-05852-0. https://doi.org/10.1007/s00268-020-05852-0
4. Kulvatunyou N, Erickson L, Vijayasekaran A, et al. Randomized clinical trial of pigtail catheter versus chest tube in injured patients with uncomplicated traumatic pneumothorax. Br J Surg. 2014;101(2):17-22. doi:10.1002/bjs.9377. https://doi.org/10.1002/bjs.9377
5. McCartt J, Ross SW, Cunningham KW, et al. A randomized non-inferiority clinical trial of 14Fr Thal versus 28Fr tube thoracostomy for traumatic hemothorax. Am Surg. 2025;91(4):579-586. doi:10.1177/00031348241308907. https://doi.org/10.1177/00031348241308907
6. Owodunni OP, Moore SA, Hynes AM. Clinical Controversies: large versus small chest tubes in trauma. Ann Emerg Med. 2025;85(1):74-75. doi:10.1016/j.annemergmed.2024.06.021. https://doi.org/10.1016/j.annemergmed.2024.06.021
7. Optimal needle length and decompression site for tension pneumothorax: a systematic review and meta-analysis with consensus recommendations on current ATLS and ETC guidelines. 2024. PMCID: PMC12087068. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087068/
8. Lesperance RN, Carroll CM, Aden JK, et al. Failure rate of prehospital needle decompression for tension pneumothorax in trauma patients. Am Surg. 2018;84(11):1750-1755. https://pubmed.ncbi.nlm.nih.gov/30747627/
9. Ciaraglia A, Smith A, Axtman B, et al. Retrospective matched cohort comparison of prehospital finger thoracostomy and needle thoracostomy performed by ground EMS. Int J Paramedicine. 2024. https://internationaljournalofparamedicine.com/index.php/ijop/article/view/2820
10. Mowery NT, Gunter OL, Collier BR, et al. Practice management guidelines for management of hemothorax and occult pneumothorax. J Trauma. 2011;70(2):510-518. doi:10.1097/TA.0b013e31820b5c31. https://doi.org/10.1097/TA.0b013e31820b5c31
11. Moore FO, Goslar PW, Coimbra R, et al. Blunt traumatic occult pneumothorax: is observation safe? Results of a prospective, AAST multicenter study. J Trauma. 2011;70(5):1019-1025. doi:10.1097/TA.0b013e318213f727. https://pubmed.ncbi.nlm.nih.gov/21610419/
12. Freeman JJ, Asfaw SH, Vatsaas CJ, et al. Antibiotic prophylaxis for tube thoracostomy placement in trauma: a practice management guideline from the Eastern Association for the Surgery of Trauma. Trauma Surg Acute Care Open. 2022;7(1):e000886. doi:10.1136/tsaco-2022-000886. https://doi.org/10.1136/tsaco-2022-000886